100 Epizód

  1. Introducing DrugChatter: Revolutionizing Information Access

    Közzétéve: 2024. 06. 25.

  2. USPTO Study Reveals Trends and Insights into Drug Patent and Exclusivity Trends in the Pharmaceutical Industry

    Közzétéve: 2024. 06. 25.

  3. Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents

    Közzétéve: 2024. 06. 24.

  4. The Intricate Journey of Drug Patents: From Filing to Expiry

    Közzétéve: 2024. 06. 20.

  5. Uncovering Lucrative Low-Competition Generic Drug Opportunities

    Közzétéve: 2024. 06. 19.

  6. Maximizing ROI with Branded Generics: A Comprehensive Guide

    Közzétéve: 2024. 06. 18.

  7. A Practical Guide to FtO Analysis for Drug Repurposing Ventures

    Közzétéve: 2024. 06. 17.

  8. Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies

    Közzétéve: 2024. 06. 17.

  9. Innovative Approaches to Extend the Life of Drug Patents

    Közzétéve: 2024. 06. 17.

  10. How long does a patent last for drugs?

    Közzétéve: 2024. 06. 12.

  11. Crucial Insights on Patent Litigation Strategies in Pharma Industry

    Közzétéve: 2024. 06. 10.

  12. Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices

    Közzétéve: 2024. 06. 06.

  13. Innovative Strategies in Drug Repurposing

    Közzétéve: 2024. 04. 23.

  14. AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research

    Közzétéve: 2024. 04. 16.

  15. Innovative Financing Models for Repurposing Generic Drugs

    Közzétéve: 2024. 04. 11.

  16. Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs

    Közzétéve: 2024. 03. 31.

  17. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Közzétéve: 2024. 03. 22.

  18. LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?

    Közzétéve: 2024. 03. 08.

  19. GELATIN-Free Medicines: Which Drugs Contain GELATIN?

    Közzétéve: 2024. 03. 06.

  20. Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma

    Közzétéve: 2024. 02. 26.

1 / 5

DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management

Visit the podcast's native language site